Artelo Biosciences, Inc. ( ARTL) - Stock Earnings
ARTL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -4.2 million USD | — USD |
| 2026Q1 | -3.0 million USD | — USD |
| 2026Q2 | -2.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ARTL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.3 million USD | — USD |
| 2024 | -9.8 million USD | — USD |
| 2025 | -12.9 million USD | — USD |
| 2026 Est. | — | — |
ARTL
Price: $3.26
52 week price:
Earnings Per Share: -11.23 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36149
Market Capitalization: 1.3 million